ADC Therapeutics SA
ADCT
$1.29
-$0.01-0.77%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 70.76% | 14.60% | 79.14% | 6.83% | -55.01% |
| Total Depreciation and Amortization | 75.16% | -75.16% | -85.75% | -84.79% | -154.77% |
| Total Amortization of Deferred Charges | 44.62% | 17.80% | 144.17% | 42.05% | 47.73% |
| Total Other Non-Cash Items | -149.36% | -28.82% | -872.19% | 11.27% | 135.10% |
| Change in Net Operating Assets | -19.63% | 83.04% | -215.48% | -95.41% | 418.47% |
| Cash from Operations | 50.98% | 47.26% | -42.43% | -18.32% | 26.66% |
| Capital Expenditure | -- | 87.88% | 100.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 87.88% | 832.22% | 100.00% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.87% | -24.35% | 135,604.65% | -- | -4.73% |
| Repurchase of Common Stock | 13.20% | -- | -8.68% | 77.47% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.11% | -315.13% | 5,197.23% | 77.47% | -4.98% |
| Foreign Exchange rate Adjustments | -96.93% | -103.11% | 92.71% | -97.94% | 1,258.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.04% | 46.00% | 213.65% | -15.38% | 6.11% |